by Monash University A collaborative study led by Monash University’s Biomedicine Discovery Institute (BDI) in Melbourne, Australia, with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), has shown that an anti-parasitic drug already available around the world kills the virus within 48 hours. The Monash Biomedicine Discovery Institute’s Dr. Kylie Wagstaff, who led...
by Adam Malecek, University of Wisconsin-Madison That’s according to research conducted by University of Wisconsin-Madison engineers, whose findings support the treatment approach at the cellular level. “There are currently no effective medical treatments for concussions and other types of traumatic brain injuries,” says Christian Franck, the UW-Madison associate professor of mechanical engineering who led the...
Imidazoline receptors I2: Looking for new therapeutic targets UNIVERSITY OF BARCELONA An article published in the Journal of Medicinal Chemistry shows a new family of molecules with high affinity to join imidazoline receptors, which are altered in the brain of those patients with neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s. According to the preclinical...
In a new study of CAR T-cell therapy for cancer, 93% of patients responded to the treatment. Two physicians had major roles in a cutting-edge clinical trial using the body’s own immune cells to fight late-stage cancer, one as a researcher and one as a patient. Senior author Patrick Reagan, an assistant professor of hematology/oncology...
Understanding how the protein tau moves between neurons offers insight into possible treatments for neurodegenerative diseases, researchers report. In the fight against neurodegenerative diseases such as frontotemporal dementia, Alzheimer’s, and chronic traumatic encephalopathy, the tau protein is a major culprit. Abundant in our brain cells, tau is normally a team player—it maintains structure and stability...
by Colorado State University Propelled by the COVID-19 pandemic, a Colorado State University research team is pursuing a vaccine that would thwart the novel coronavirus using a genetically modified form of the well-known probiotic Lactobacillus acidophilus, a bacterium commonly ingested in yogurt and other foods for gut health. The beneficial bacterium thrives exactly where the...
by CU Anschutz Medical Campus Cells have a big decision: Should they replicate or sleep? Healthy cells can go either way. Cancer cells’ replication switches are stuck in the ‘on’ position. Now a study by University of Colorado Cancer Center researchers working at CU Boulder’s BioFrontiers Institute and published today in the journal Science overturns...
by Dana-Farber Cancer Institute In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute and the Mayo Clinic. The results, published...
by University of North Texas Health Science Center When news of the coronavirus emerged from Wuhan, China, Kunlin Jin, Ph.D., and a team of international researchers quickly joined forces to fight the mysterious disease. Dr. Jin relied on his more than 20 years of knowledge about stem cells to work with an international team driven...
by Craig Janes, The Conversation As the coronavirus pandemic continues its spread, it has infected more than half a million people and killed tens of thousands on nearly every continent. With offices shut down, people staying at home and hospitals bracing for an influx of patients, many people are unsure of what’s safe and what’s...
